Berglund-Brown, Isabella
Nissen, Emily
Koestler, Devin C.
Butler, Rondi A.
Eliot, Melissa N.
Padbury, James F.
Salas, Lucas A.
Molinaro, Annette M.
Christensen, Brock C.
Wiencke, John K.
Kelsey, Karl T. http://orcid.org/0000-0002-2302-1600
Funding for this research was provided by:
Foundation for the National Institutes of Health (R01CA216265, R01CA207360, R01CA253976)
UCSF Brain Tumor SPORE (P50CA097257)
National Cancer Institute (P30 CA168524)
Kansas Institute for Precision Medicine COBRE (Supported by the National Institute of General Medical Science (P20 GM130423)
Kansas IDEA Network Of Biomedical Research Excellence (P20 GM103418)
U.S. Department of Defense (W81XWH-20-1-0778)
National Institute of General Medical Sciences (P20GM104416-09/8299)
Robert Magnin Newman Endowed Chair in Neuro-oncology
Article History
Received: 2 December 2021
Accepted: 11 February 2022
First Online: 21 February 2022
Declarations
:
: The Institutional Review Boards from respective institutions approved biological sample collections. Written informed consent was received from all of the participating adults for all of the studies involved in this work. The analysis presented here was conducted on deidentified whole blood samples.
: Not applicable.
: JKW and KTK are co-founders of Cellintec, which had no role in this research. The other authors declare no potential conflicts of interest.